Oramed CFO David Silberman resigns, effective July 12, 2024

ORAMED PHARMACEUTICALS INC.

David Silberman stepped down as CFO, Treasurer and Secretary for personal reasons.
His resignation is effective July 12, 2024, with a transition period until then.
Company has initiated a search for a new CFO to replace Silberman.
The departure is voluntary and not due to any disagreement with Oramed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Silberman

Chief Financial Officer, Treasurer and Secretary

ORMP · ORAMED PHARMACEUTICALS INC.

Effective: 2024-07-12
Filed: May 13, 2024, 7:59 PM ET

On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Silberman resigned as Chief Financial Officer, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC..

Action: resigned
Role: Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.

View on SEC.gov

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-041847

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.